The CTD² Network and Cancer Systems Biology Consortium organized a virtual symposium series titled “Multidisciplinary Approaches to Understand Cancer Treatment Resistance”. Please join us on 12/2, 12/16, and 12/17. Click here to view the registration website.
CTD² Data Portal
The CTD2 Network aims to understand the tumor heterogeneity and drug resistance for the development of efficient strategies to identify optimal combinations of small-molecules or immunotherapy with small molecules. The CTD2 Data Portal provides access to raw/analyzed primary data generated from different types of approaches e.g. chemical genetics (small-molecules, natural products); genome-wide gain-of-function (cDNA expression libraries, CRISPRa); genome-wide loss-of-function (siRNA, shRNA, CRISPR/Cas9, CRISPRi); protein-protein interactions; and in vivo gain and loss-of function studies.